Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021


HomeFDAFX Solutions Receives FDA 510(k) Clearance for Lateralized & Augmented Glenoid Baseplates

FX Solutions Receives FDA 510(k) Clearance for Lateralized & Augmented Glenoid Baseplates

FX Solutions received 510k clearance for its lateralized and augmented glenoid baseplates. With these additions, FX brings ten additional glenoid baseplate options to the market.


The glenoid baseplates are available in 24mm options with additional lateralization, augments, and lateralized augments. The lateralized glenoid baseplates are available with a central screw or central post option. The augmented glenoid baseplates are available with the central screw option only.

The Humelock glenoid baseplate is a 24mm round baseplate available in four options: baseplate with a central cannulated post, baseplate with a central screw (with seven 4.5mm central screw length options from 8-20mm in 2mm increments), lateralized baseplate with +3mm or +6mm added, and augmented baseplate with 7.5° (3mm thick) or 15° (6.5mm thick) half-wedge added, +0, +3mm, or +6mm lateralized. Lateralization and augmentation are added under the flat surface of the baseplate and above the post.

“As we continue to grow the FX portfolio, we evolve ever closer to providing a tailor-made approach for surgeons using our portfolio. They may be able to adapt the system to the patient rather than the patient to our system. This clearance of the lateralized and augmented glenoid baseplates is truly significant for our portfolio and the treatment of patients’ shoulders,” said Baptiste Martin, CEO of FX Shoulder USA.

With the launch of the lateralized glenoid baseplates FX will include upgrades of their current instrumentation to include a first-to-market and completely unique patent-pending trialing system for the reverse glenoid construct. This features a monobloc trial consisting of the glenosphere and lateralized glenoid baseplate together to better replicate the feel of the definitive implants.

FX continues to innovate based upon surgeon feedback and market trends with a focus exclusively on shoulder arthroplasty with the goal of becoming a global market leader in this segment.


Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy